Related Experiment Video
Updated: May 5, 2026

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Anti-apoptotic pathways in bone marrow and megakaryocytes in myeloproliferative neoplasia
Suzanne M Koopmans1, Harry C Schouten, Arienne M W van Marion
1Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.
Objective:
Proliferative activity contributes to bone marrow cellularity in myeloproliferative neoplasia (MPN). Megakaryocytes are the most important cells in MPN bone marrow pathology. JAK2(V617F) mutation constitutively activates JAK2, pErk (phosphorylating extracellular signal-regulated kinase) and PI3K (phosphatidylinositol 3-kinase)-Akt signaling. Erk is involved in megakaryocyte differentiation, PI3K-Akt inhibits megakaryocyte apoptosis via Bcl-xL and two downstream effectors (p70S6k and Bnip3). Immunohistochemic expression of phosphorylated Erk, Akt, p70S6k and Bnip3 was studied along with microvessel density (MVD) in MPN bone marrow and megakaryocytes.
Methods:
36 essential thrombocythemia (ET), 25 polycythemia vera and 45 primary myelofibrosis patients were analyzed for pErk, pAkt, Bnip3, p70S6k and MVD expression by immunostaining bone marrow biopsy sections followed by automated image analysis. JAK2(V617F) was analyzed through real-time PCR in blood samples.
Results:
pErk and pAkt were significantly higher expressed in MPN megakaryocytes, mainly in ET patients, compared to controls. Bnip3 was higher expressed in bone marrow of control patients and in MPN megakaryocytes. Mainly in ET patients, MPN megakaryocytes showed higher p70S6k expression compared to controls.
Conclusion:
Increased bone marrow cellularity in MPN patients might be influenced by increased pErk, pAkt and decreased Bnip3 expression. A dominant role for megakaryocytes in ET patients was shown. Increased amounts of megakaryocytes in MPN patients can be due to increased pAkt and p70S6k.
Insights
Myeloproliferative neoplasia (MPN) bone marrow cellularity may increase due to higher pErk and pAkt signaling and lower Bnip3 expression. Megakaryocytes play a key role, especially in essential thrombocythemia (ET).
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Bone marrow cellularity in myeloproliferative neoplasia (MPN) is linked to proliferative activity.
- Megakaryocytes are central to MPN bone marrow pathology.
- The JAK2(V617F) mutation activates JAK2, pErk, and PI3K-Akt signaling pathways, influencing megakaryocyte differentiation and apoptosis.
Purpose of the Study:
- To investigate the expression of phosphorylated Erk (pErk), Akt (pAkt), p70S6k, and Bnip3 in MPN bone marrow.
- To assess the correlation between these markers and microvessel density (MVD) in MPN.
- To elucidate the role of megakaryocytes in MPN pathogenesis, particularly in essential thrombocythemia (ET).
Main Methods:
- Immunohistochemical analysis of pErk, pAkt, Bnip3, p70S6k, and MVD in bone marrow biopsy sections from 36 ET, 25 polycythemia vera, and 45 primary myelofibrosis patients.
- Automated image analysis for quantitative assessment of marker expression.
- Real-time PCR for JAK2(V617F) mutation analysis in blood samples.
Main Results:
- MPN megakaryocytes exhibited significantly higher expression of pErk and pAkt compared to controls, predominantly in ET patients.
- Bnip3 expression was elevated in MPN megakaryocytes but higher in control bone marrow.
- p70S6k expression was increased in MPN megakaryocytes, especially in ET patients, relative to controls.
Conclusions:
- Elevated pErk and pAkt, coupled with decreased Bnip3, may contribute to increased bone marrow cellularity in MPN.
- Megakaryocytes demonstrate a dominant role in ET pathogenesis.
- Increased megakaryocyte counts in MPN could be attributed to enhanced pAkt and p70S6k signaling.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Regulation of Hematopoietic Stem Cells
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

